Се вчитува

Slzii.com Пребарување

Пребарување (Вести)

First long-acting, intra-articular multikinase inhibitor for OA

First long-acting, intra-articular multikinase inhibitor for OA
Bioworld english science

Researchers from Rottapharm Biotech Srl have reported preclinical efficacy data on CR-10049, a long-acting osteoarthritis-targeted multikinase inhibitor, designed to treat both osteoarthritis pain and inflammatory joint degeneration.
2026-05-11 13:00:00

што правиш?
0.074960947036743


Вести
Вести

Најнови вести и наслови
Researchers from Rottapharm Biotech Srl have reported preclinical efficacy data on CR-10049, a long-acting osteoarthritis-targeted multikina...
Вести